These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14900966)

  • 1. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 3. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems of prothrombin determination; comparative studies with the one- and two-phase method in the control of the dicoumarin medication].
    ARNOLDS P; ERLEMANN E
    Klin Wochenschr; 1952 Jan; 30(1-2):22-5. PubMed ID: 14939638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 6. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
    TRONNBERG G
    Nord Med; 1955 Jun; 53(26):1028-9. PubMed ID: 13244879
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of two methods for determining prothrombin during dicumarol therapy.
    BEGTRUP H
    Acta Med Scand; 1954; 150(1):11-6. PubMed ID: 13196956
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():540-8. PubMed ID: 14209214
    [No Abstract]   [Full Text] [Related]  

  • 11. The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
    MANCHESTER B; RABKIN B
    Circulation; 1954 Nov; 10(5):691-8. PubMed ID: 13209750
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimentally induced changes in the prothrombin level of the blood; quantitative studies in dogs given dicumarol; the effect of methylxanthines on prothrombin per se and when administered with dicumarol.
    QUICK AJ
    J Biol Chem; 1945; 161():33-44. PubMed ID: 21005712
    [No Abstract]   [Full Text] [Related]  

  • 13. Dilution curves and accuracy in prothrombin estimations during hepatitis and dicumarol therapy.
    MULLERTZ S
    Scand J Clin Lab Invest; 1953; 5(2):179-87. PubMed ID: 13089547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    HOLYOKE JB; WHEELWRIGHT HJ
    N Engl J Med; 1952 Jan; 246(1):15-7. PubMed ID: 14882481
    [No Abstract]   [Full Text] [Related]  

  • 16. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
    REHBEIN A; JARETZKI A; HABIF DV
    Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelets and the coagulation defect caused by dicumarol.
    MANN FD; HURN M; BARKER NW
    Am J Clin Pathol; 1951 Sep; 21(9):814-9. PubMed ID: 14877771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of coagulation time in dicumarol therapy].
    DELLA SANTA R; FALLER R
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1242-4. PubMed ID: 14913081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dicumarol treatment in general practice].
    SCHWAN W
    Ther Ggw; 1952 Oct; 91(10):370-1. PubMed ID: 13029065
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.
    FIELD JB
    Am J Physiol; 1952 Feb; 168(2):287-91. PubMed ID: 14903142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.